Kezar Life Sciences Inc (KZR)

Kezar Life Sciences (KZR) Stock Price & Analysis


KZR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.25 - $11.02
Previous Close$2.44
Average Volume (3M)1.05M
Market Cap
Enterprise Value-$60.64M
Total Cash (Recent Filing)$257.67M
Total Debt (Recent Filing)$20.72M
Price to Earnings (P/E)-2.3
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding72,407,215
10 Day Avg. Volume760,519
30 Day Avg. Volume1,049,864
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)0.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.76
Price Target Upside557.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kezar Life Sciences Inc’s price range in the past 12 months?
Kezar Life Sciences Inc lowest stock price was $2.25 and its highest was $11.02 in the past 12 months.
    What is Kezar Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Kezar Life Sciences Inc’s upcoming earnings report date?
    Kezar Life Sciences Inc’s upcoming earnings report date is Aug 10, 2023 which is in 61 days.
      How were Kezar Life Sciences Inc’s earnings last quarter?
      Kezar Life Sciences Inc released its earnings results on May 11, 2023. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.287 by -$0.023.
        Is Kezar Life Sciences Inc overvalued?
        According to Wall Street analysts Kezar Life Sciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Kezar Life Sciences Inc pay dividends?
          Kezar Life Sciences Inc does not currently pay dividends.
          What is Kezar Life Sciences Inc’s EPS estimate?
          Kezar Life Sciences Inc’s EPS estimate is -$0.32.
            How many shares outstanding does Kezar Life Sciences Inc have?
            Kezar Life Sciences Inc has 72,407,210 shares outstanding.
              What happened to Kezar Life Sciences Inc’s price movement after its last earnings report?
              Kezar Life Sciences Inc reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.287. Following the earnings report the stock price went up 0.769%.
                Which hedge fund is a major shareholder of Kezar Life Sciences Inc?
                Among the largest hedge funds holding Kezar Life Sciences Inc’s share is Moore Capital Management LP. It holds Kezar Life Sciences Inc’s shares valued at 266K.


                  Kezar Life Sciences Stock Smart Score

                  The Kezar Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Kezar Life Sciences Inc

                  Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which discovers and develops novel small molecule therapeutics to treat autoimmunity and cancer. The firm specializes in the areas of protein degradation and protein secretion to discover & develop novel therapies for the treatment of serious and unmet medical needs. Its product include KZR-616, an immunoproteasome inhibitor, has completed testing in healthy volunteers. The company was founded by John Fowler, Christopher J. Kirk and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding KZR

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  iShares Russell 3000 ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold KZR. The ETFs are listed according to market value of KZR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intra-Cellular Therapies
                  Corvus Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis